Review
[Screening of prostate carcinoma]
[Article in
German]
Affiliations
- PMID: 7541568
Item in Clipboard
Review
[Screening of prostate carcinoma]
[Article in
German]
Ther Umsch.
1995 Jun.
Abstract
Taking into consideration the height costs of screening healthy men from general population at risk for prostate cancer, we do not recommend prostate cancer screening except for scientific reasons in prospective random trials. To diagnose prostate cancer we know the following methods for patients with prostatic problems: DRE = (digital rectal examination) PSA = (prostate-specific antigen) TRUS = (transrectal ultrasonography) The possible validity of DRE, PSA and TRUS are discussed. The best and most economic way of diagnosing prostate cancer is a combination of DRE and PSA.
Similar articles
-
Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.Cancer Causes Control. 2007 Nov;18(9):931-7. doi: 10.1007/s10552-007-9031-7. Epub 2007 Jul 20. Cancer Causes Control. 2007. PMID: 17641982
-
Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.J Exp Clin Cancer Res. 2001 Dec;20(4):473-80. J Exp Clin Cancer Res. 2001. PMID: 11876539
-
Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.Urol Int. 2007;79(4):336-44. doi: 10.1159/000109720. Urol Int. 2007. PMID: 18025853
-
Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.In Vivo. 1994 May-Jun;8(3):423-7. In Vivo. 1994. PMID: 7803728 Review.
-
Prostate cancer screening.Prim Care. 1992 Sep;19(3):637-49. Prim Care. 1992. PMID: 1384077 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous